In this episode, Prof. Frank Holz leads a panel discussion on a major leap forward in retinal prosthesis: the Prima system for geographic atrophy. Joined by Dr. Mahi Muqit and Prof. Lars-Olof Hattenbach, they explore how their extraordinary wireless subretinal implant is restoring visual perception in late-stage AMD. 

In this episode, Profs. Lejla Vajzovic (USA), Sandrine Zweifel (Switzerland), and Heinrich Heimann (UK) reflect on a fantastic few days in Paris and share their highlights from the 2025 programme for you to watch back through the portal.

Euretina President Prof. Anat Loewenstein speaks with Prof. Ursula Schmidt-Erfurth, 25th Euretina Lecturer, about her groundbreaking career in retinal disease, from imaging innovations to AI-driven early detection. They discuss the EU-funded iScreen project, the future of AMD management, and the significance of two women presidents (past and present) as Euretina celebrates its 25th anniversary in Paris

Ahead of his Gisbert Richard Lecture at this year’s Euretina Congress in Paris, Prof. Jean-François Korobelnik joins Prof. Nicole Eter to reflect on a career at the forefront of retinal research. From surgical breakthroughs to his leadership of the E3 consortium, and his cautious optimism for AI, Prof. Korobelnik shares insights on past progress and future priorities in retina

Ahead of her Kreissig Award Lecture at the Euretina Congress in Paris, Professor Maria Berrocal (Puerto Rico) joins Euretina past president Alistair Laidlaw to discuss why time-tested treatments like PRP and scleral buckling still matter. They explore the risks of over-reliance on anti-VEGF in proliferative diabetic retinopathy, the decline in buckle training, and how chandelier techniques could revive it

In this thought-provoking episode, Professor Tariq Aslam and Retina International’s Avril Daly join Jonathan McCrea to explore the emotional and psychological dimensions of retinal disease. From the power of empathy in clinical care to the need for integrated mental health services, the discussion highlights why supporting patients beyond the medical chart is more vital than ever—especially in an AI-driven world.

Ahead of her Ophthalmologica Lecture at this year’s Euretina Congress, Dr. Maria Vittoria Cicinelli joins Professor Bahram Bodaghi to explore the evolving understanding of white spot syndromes. From classic presentations of punctate inner choroidopathy (PIC) to emerging imaging insights and therapeutic uncertainties, the conversation highlights unmet needs, research gaps, and practical implications for clinicians managing posterior uveitis

In this episode, Prof. Martin Zinkernagel and Dr. Matias Iglicki spotlight Ophthalmologica’s new article collection on submacular hemorrhages. They explore key findings from four studies covering imaging, surgical strategies, and real-world outcomes, offering timely insights into managing this vision-threatening condition.

Ever considered broadening your professional horizons with an ophthalmology fellowship abroad? In this insightful episode, Dr. Peter Kiraly (Manchester Royal Eye Hospital) and Dr. Elon van Dijk (Leiden University Medical Center and Rotterdam Eye Hospital) share their personal journeys and practical advice from fellowships in the UK and Australia. Chaired by Jonathan McCrea

When should you refer and what should you include? Oncologists Hibba Quhill, Iwona Rospond-Kubiak, and Emine Kilic share practical, experience-based advice on improving referral pathways in ocular oncology. From triage strategies to imaging essentials, this episode covers what referring clinicians need to know to ensure timely and effective patient care

Dr. Sarah Mrejen (France), Associate Professor Salomon Cohen (France), and Associate Professor Dinah Zur (Israel) explore how neovascular AMD phenotype may influence imaging choices, patient dialogue, and treatment plans. From proactive vs. conservative strategies to new anti-VEGF agents and PCV diagnosis, this expert-led discussion offers key insights into personalising care in retinal disease.

Prof. Zohar Habot-Wilner (Tel Aviv University) chairs a rich discussion with Prof. Sofia Androudi (University of Thessaly, Greece) and Prof. Sarah Touhami (University of Sorbonne) on managing retinal and uveitic diseases during pregnancy. They explore safe diagnostic tools, therapeutic dilemmas like Ranibizumab vs. Ozurdex, and the effects of pregnancy-related hormonal shifts—highlighting the importance of multidisciplinary collaboration in high-risk cases

What are hyperreflective foci, and why do they matter in AMD? Prof. Stella Vujosevic is joined by Prof. Christine Curcio (University of Alabama at Birmingham) and Prof. Srinivas Sadda (Doheny Eye Institute, UCLA) to explore their significance—from donor eye histology to OCT imaging. They discuss key biomarkers, clinical implications, and how HRF can help guide treatment decisions in age-related macular degeneration

What causes central serous chorioretinopathy (CSC), and how should it be managed? In this episode, experts Camiel Boon, Sobha Sivaprasad, and Gemmy Cheung discuss the latest insights into CSC and the pachychoroid spectrum, including new imaging findings, risk factors, and treatment options like PDT, laser, and anti-VEGF

Uveal melanoma remains a significant challenge, with genetic alterations playing a crucial role in treatment decisions. In this episode, Prof Jens Folke Kiilgaard (Denmark) and Dr Emine Kilic (Netherlands) join Prof Antonia Joussen (Germany) to explore why metastases persist despite primary tumor treatment, the limitations of checkpoint inhibitors, and the latest on Tebentafusp and Darovasertib. We also discuss the role of adjuvant and neoadjuvant therapies and emerging T-cell therapies. Join us for an insightful discussion on the future of uveal melanoma treatment

In this episode, Chair Alistair Laidlaw (UK) chats to Mario Romano (Italy) and Stratos Gotzaridis (Greece) about some of the considerations and complications surrounding the use of intraocular tamponades. They also discuss the upcoming Special Focus Meeting in Athens which will centre on vitreoretinal surgery (VR)

In this final episode of highlights from the Barcelona congress 2024, we’ll hear from Dr Arshad Khanani (USA) about clinical trials, long term-data and the importance of personalising the treatment to the patient

In this second episode looking at highlights from the Barcelona congress, we'll hear about AI and sustainability in ophthalmology from Prof Jean-Francois Korobelnik of University Hospital Bordeaux

Barcelona, We love you! Over the next few episodes, we'll be hearing from 3 different sub-specialty experts about their favourite picks from the excellent Euretina Congress this year. This week, we hear from Ms. Rumana Hussain, Consultant Ophthalmologist specialising in Ocular Oncology and VR surgery at Liverpool University Trust Foundation Hospitals

In this episode, Prof Nicole Eter (Germany) speaks with Dr Yousif Subhi, this year's Ophthalmologica lecture about his work in meta-analyses, evidence synthesis, determination of best-practice, and clinical research